UnitedHealth Group Incorporated (NYSE:UNH) Holdings Cut by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 60.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,000 shares of the healthcare conglomerate's stock after selling 7,500 shares during the quarter. UnitedHealth Group makes up 1.4% of Sivik Global Healthcare LLC's investment portfolio, making the stock its 29th largest position. Sivik Global Healthcare LLC's holdings in UnitedHealth Group were worth $2,619,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Financial Management Professionals Inc. boosted its position in UnitedHealth Group by 0.8% during the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after purchasing an additional 17 shares during the period. Richwood Investment Advisors LLC boosted its position in UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after purchasing an additional 20 shares during the period. Global Wealth Strategies & Associates boosted its position in UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after purchasing an additional 20 shares during the period. 44 Wealth Management LLC boosted its position in UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock worth $662,000 after purchasing an additional 21 shares during the period. Finally, Prentice Wealth Management LLC boosted its position in UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock worth $1,278,000 after purchasing an additional 21 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director now owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John H. Noseworthy acquired 300 shares of the firm's stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $312.16 per share, with a total value of $93,648.00. Following the purchase, the director now directly owns 6,063 shares in the company, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

NYSE UNH traded down $5.16 on Friday, hitting $302.04. The stock had a trading volume of 16,024,789 shares, compared to its average volume of 7,346,801. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market cap of $273.99 billion, a price-to-earnings ratio of 12.65, a P/E/G ratio of 1.42 and a beta of 0.44. The company's 50-day moving average is $359.15 and its two-hundred day moving average is $462.77.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter last year, the company posted $6.91 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.93%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on UNH shares. Oppenheimer cut their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Raymond James Financial lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Wall Street Zen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Barclays cut their price objective on shares of UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a report on Monday, June 2nd. Finally, Morgan Stanley cut their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $427.09.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.